Purpose of this paper is to review all the phases that in-volved, for the first time, the SC of Hematology and the SC of Transfu-sion Medicine, specifically, the CSE Processing laboratory, in imple-menting an innovative operative protocol of gene immunotherapydue to the inclusion of the first patient, affected by diffuse large B-celllymphoma (DLBCL), stage IV, into the CAR-T therapeutic program.The program took place within the SS Antonio e Biagio e Cesare Ar-rigo Hospital of Alessandria.
CAR-T therapy: the role of the hematopoietic stem cell processing laboratory
Mauro Patrone;Marco Ladetto;Lia Mele
2022-01-01
Abstract
Purpose of this paper is to review all the phases that in-volved, for the first time, the SC of Hematology and the SC of Transfu-sion Medicine, specifically, the CSE Processing laboratory, in imple-menting an innovative operative protocol of gene immunotherapydue to the inclusion of the first patient, affected by diffuse large B-celllymphoma (DLBCL), stage IV, into the CAR-T therapeutic program.The program took place within the SS Antonio e Biagio e Cesare Ar-rigo Hospital of Alessandria.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
9451-Article Text-67687-1-10-20211227.pdf
file ad accesso aperto
Licenza:
Creative commons
Dimensione
1.29 MB
Formato
Adobe PDF
|
1.29 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
